Regenerative Skin Treatments
Compare polynucleotides, hyaluronic-acid skin boosters, PRP and exosome-based skin treatments in plain English. Learn how their mechanisms, evidence, downtime and suitability differ.
The Short Answer
Polynucleotides, skin boosters, PRP and exosome-based treatments are not four brands of the same treatment.
Polynucleotides are injectable nucleotide-chain products used for skin-quality goals.
Skin boosters are usually injectable formulations, often based on hyaluronic acid, aimed at hydration and skin quality.
PRP uses a concentrate prepared from the patient’s own blood.
Exosome-based products are a varied emerging category commonly used topically alongside procedures.
The best choice depends on the goal and the exact product.
They are all frequently described using the same words:
Glow.
Repair.
Regeneration.
Collagen.
Hydration.
Rejuvenation.
But those words can hide very different mechanisms.
If you are comparing treatment options, the useful question is not:
“Which one is newest?”
It is:
“What exactly is this treatment designed to do, and how strong is the evidence for my concern?”
Polynucleotides are injectable chains of nucleotides used in aesthetic medicine with the aim of supporting skin quality and tissue-repair pathways.
They are often considered for crepey skin, fine lines and delicate areas, depending on the product and assessment.
Published reviews describe encouraging improvements in texture, wrinkles and elasticity, but the evidence base remains smaller and less standardised than many marketing claims imply.
Swelling, bruising and injection-site effects can occur, and suitability depends on medical history and the product used.
“Skin booster” is a broad commercial term rather than one single formulation.
Many injectable skin boosters are based on hyaluronic acid designed primarily to improve hydration and skin quality rather than to create conventional contouring volume.
Different products vary in concentration, cross-linking and intended placement.
A product that contains hyaluronic acid is not automatically the same as dermal filler.
But the fact that it is injectable still means vascular, infection and other procedure-related risks need to be considered.
Platelet-rich plasma is prepared from a sample of your own blood.
The blood is processed to concentrate platelets, then the resulting preparation may be used by injection or within a procedure according to protocol.
Systematic reviews suggest potential improvements in selected measures including elasticity and skin thickness, although preparation methods and outcomes differ between studies.
Because it is autologous, allergic reaction to a foreign active material may be less of a concern, but sterile blood handling and injection safety remain essential.
Exosomes are microscopic extracellular vesicles used by cells for signalling.
Commercial aesthetic products described as exosome-based vary considerably by source, manufacturing and formulation.
At Transform Beauty, any exosome-based product should be used only according to the product’s compliant intended route and the clinic’s approved protocol.
A topical adjunct after microneedling or resurfacing should not be described as equivalent to an injectable exosome therapy.
The scientific field is promising, but 2026 systematic-review evidence still describes heterogeneity and a need for more standardised, high-quality human studies.
Skin quality, delicate areas
and crepiness
Hydration and
skin feel
Autologous blood-derived
treatment approach
Emerging adjunct category
depending on exact product
A suitable skin booster may be considered.
Polynucleotides may be considered in appropriate clients.
PRP may be an option where clinically appropriate.
Ask exactly what the product is, why it is being combined with the procedure and what evidence supports that use.
These are starting points, not prescriptions. The same visible concern can have different causes.
We do not compare these treatments by trend alone.
The treatment goal.
Skin thickness and sensitivity.
The treatment area.
Previous filler or procedures.
Medical history.
Tolerance for injections or downtime.
The quality of the evidence.
Number of sessions.
Maintenance.
Total cost.
We also discuss alternatives.
Sometimes microneedling, fractional CO2, HIFU, a peel, skincare or simply no treatment is a better fit.
The UK is moving toward tighter licensing of non-surgical cosmetic procedures.
Government proposals classify many injectable and needle-based procedures according to risk and envisage practitioner and premises requirements.
You do not need to wait for every regulation to be finalised to ask sensible questions now.
What is the exact product?
Is it traceable?
Is this the intended route of use?
Who is treating me?
What training and insurance apply?
What complications can occur?
What happens if something goes wrong?
Safety, traceability and correct use matter more than how fashionable the treatment sounds.
Neither is universally better.
Polynucleotides and skin boosters have different compositions and goals.
Choice depends on the concern, product, area, anatomy and medical suitability.
“Vampire facial” is a marketing term often used for combinations involving microneedling and PRP.
The exact procedure can vary, so ask what is actually being performed.
Products and regulations vary.
Do not assume an exosome-branded product is intended or authorised for injection.
At Transform Beauty, route of use must match the specific product and approved clinic protocol.
Sometimes.
But combination does not automatically improve results.
Timing, skin recovery, interaction with other procedures and total risk should be planned individually.
Consultation-Led Skin Planning
A consultation can help clarify whether your main concern is hydration, texture, crepiness, skin quality or something better addressed with a different treatment entirely.
This article is provided for general education about aesthetic and skin-treatment options only. It is not a substitute for individual medical advice, diagnosis or treatment. Polynucleotides, injectable skin boosters, PRP and other needle-based procedures can cause side effects and complications, and suitability varies between individuals. Evidence, regulatory status and intended routes of use also vary between specific products. Any treatment should follow appropriate consultation, consent, product traceability and professional assessment.
